Ubs Oconnor LLC Avantor, Inc. Transaction History

Ubs Oconnor LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$20.23 - $23.33 $1.88 Million - $2.17 Million	-93,000 Reduced 86.54%	14,470 $305,000
Q2 2023 Aug 14, 2023	BUY	$18.72 - $21.54 $2.01 Million - $2.31 Million	107,470 New	107,470 $2.21 Billion
Q1 2023 May 15, 2023	SELL	$20.07 - $25.1 $1.74 Million - $2.17 Million	-86,556 Reduced 43.09%	114,333 $2.42 Million
Q4 2022 Feb 14, 2023	SELL	$19.22 - $22.8 $2.56 Million - $3.04 Million	-133,281 Reduced 39.88%	200,889 $0
Q3 2022 Nov 14, 2022	BUY	$19.6 - $32.33 $940,800 - $1.55 Million	48,000 Added 16.77%	334,170 $6.55 Billion
Q2 2022 Aug 12, 2022	BUY	$29.35 - $34.19 $6.29 Million - $7.33 Million	214,400 Added 298.73%	286,170 $8.9 Million
Q1 2022 May 16, 2022	BUY	$32.56 - $40.56 $2.34 Million - $2.91 Million	71,770 New	71,770 $2.43 Million

557

657M

3.97M

4.97M

Ticker AVTR
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 674,035,008
Market Cap $18.2B
Description
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulate...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.